# Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program

> **NCT07562347** · — · NOT_YET_RECRUITING · sponsor: **IR INNOVATE RESEARCH PRIVATE LIMITED** · enrollment: 120 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Envafolimab

## Key facts

- **NCT ID:** NCT07562347
- **Lead sponsor:** IR INNOVATE RESEARCH PRIVATE LIMITED
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-01
- **Final completion:** 2027-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07562347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07562347, "Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07562347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*